27 April, 2020
The Pharmaceutical Benefits Advisory Committee has announced disappointing outcomes for PBS inclusion of certain MS medications following its March meeting.
21 April, 2020
People with MS sharing their data with their healthcare teams accelerates our understanding of MS in the COVID-19 era and this data drives COVID-19 advice.
21 April, 2020
You, our donors and supporters, are the engine keeping us going. You are the reason MS research can and will continue in these challenging times. Thank you!
Dr Jo Lane
Australian National University, ACT
Dr Matthew Nangle
The University of Queensland, QLD
Professor Gabrielle Belz
The Walter and Eliza Hall Institute of Medical Research, VIC
